Physician profile
Ronald A Hyde
NPI 1215127162
$15,324.95
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $12.72 · 2021: $11K · 2022: $4,017 · 2023: $24.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,054.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.15 | 2019 | |
| Alexion Pharmaceuticals, INC. | $32.96 | 2019 | |
| Emd Serono, INC. | $31.80 | 2019-2020 | |
| Cook Medical LLC | $30.98 | 2019 | |
| Janssen Biotech, INC. | $26.99 | 2019 | |
| Genentech USA, INC. | $24.35 | 2023 | Rozlytrek, Alecensa, Tecentriq |
| Celgene Corporation | $16.96 | 2019 | |
| Daiichi Sankyo INC. | $15.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.84 | 2019 | |
| Glaxosmithkline, LLC. | $13.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.15 | 2019 | |
| Integra Lifesciences Corporation | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.